Article Data

  • Views 517
  • Dowloads 139

Original Research

Open Access

Sentinel lymph node biopsy in vulvar cancer: a multicenter evaluation of procedure’s feasibility for Israeli patients

  • Y. Raz1,†
  • G. Bibi1,†
  • A. Ben-Arie2
  • M. Meirovitz3
  • S. Schneebaum4
  • D. Grisaru1,*,

1Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv (Israel)

2Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel, Affiliated to the Hebrew University “Hadassah” Medical School, Jerusalem (Israel)

3Department of Obstetrics and Gynecology, Soroka Medical Center, Affiliated to Ben Gurion University of the Negev, Beer Sheva (Israel)

4Radio Guided Surgery Unit, Department of Surgery, Tel Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv (Israel)

DOI: 10.12892/ejgo3656.2018 Vol.39,Issue 1,February 2018 pp.14-18

Published: 10 February 2018

*Corresponding Author(s): D. Grisaru E-mail: grisaro@post.tau.ac.il

† These authors contributed equally.

Abstract

Purpose: To evaluate the accuracy, safety, and outcome of sentinel lymph node biopsy (SLNB) in early-stage vulvar cancer and determine the applicability of this procedure for selected patients in Israel. Materials and Methods: Forty-five patients with T1 squamous cell carcinoma (SCC) of the vulva who underwent surgery with SLNB between 2002-2011 were included. SLN was detected using both radioactive tracer and blue dye. All resected nodes underwent pathological examination. The accuracy, recurrence rates, and complications of the procedure were analyzed. Results: There was a significant correlation between radioactive reading intensity and SLN detection in frozen section (p < 0.0003, p < 0.0001). A weaker correlation existed with use of blue dye (p = 0.04, p = 0.09). For metastatic LNs, the detection rates of both agents were similar. The false negative for metastatic SLN detection in frozen section was 12.5%, while the false positive was 2%. The rate of inguinal recurrence without local recurrence was 4.4%. For patients with unifocal vulvar disease and a negative sentinel node the seven-year survival rate was 94%. Conclusion: SLNB is an effective and safe procedure for Israeli patients with earlystage SCC of the vulva. Recurrence rates and disease free survival are similar to the reported literature and morbidity is low compared to radical inguinal LNs resection.


Keywords

Vulva; Carcinoma; Sentinel lymph node biopsy.

Cite and Share

Y. Raz,G. Bibi,A. Ben-Arie,M. Meirovitz,S. Schneebaum,D. Grisaru. Sentinel lymph node biopsy in vulvar cancer: a multicenter evaluation of procedure’s feasibility for Israeli patients. European Journal of Gynaecological Oncology. 2018. 39(1);14-18.

References

[1] Menczer J., Voliovitch Y., Modan B., Modan M., Steinitz R.: “Some epidemiologic aspects of carcinoma of the vulva in Israel”. Am. J. Obstet. Gynecol., 1982, 143, 893.

[2] Menczer J., Barchana M., Andreev H., Arbel-Alon S., Modan B.: “Selected epidemiological time trends of vulvar carcinoma in Israel”. Int. J. Gynecol. Cancer, 1999, 9, 24.

[3] Paladini D., Cross P., Lopes A., Monaghan J.M.: “Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva”. Cancer, 1994, 74, 2491.

[4] Hacker N.F., Van der Velden J.: “Conservative management of early vulvar cancer”. Cancer, 1993, 71, 1673.

[5] Homesley H.D., Bundy B.N., Sedlis A., Yordan E., Berek J.S., Jahshan A., et al.: “Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study)”. Gynecol. Oncol., 1993, 49, 279.

[6] Zivanovic O., Khoury-Collado F., Abu-Rustum N.R., Gemignani M.L.: “Sentinel lymph node biopsy in the management of vulvar carcinoma, cervical cancer, and endometrial cancer”. Oncologist, 2009, 14, 695.

[7] Terada K.Y., Shimizu D.M., Wong J.H.: “Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva”. Gynecol. Oncol., 2000, 76, 40.

[8] Plante M., Renaud M.C., Roy M.: ”Sentinel node evaluation in gynecologic cancer”. Oncology, 2004, 18, 75.

[9] Sliutz G., Reinthaller A., Lantzsch T., Mende T., Sinzinger H., Kainz C., et al.: “Lymphatic mapping of sentinel nodes in early vulvar cancer”. Gynecol. Oncol., 2002, 84, 449.

[10] Covens A., Vella E.T., Kennedy E.B., Reade C.J., Jimenez W., Le T.: “Sentinel lymph node biopsy in vulvar cancer: Systematic review

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top